Cargando…

Treatments in Alzheimer’s disease

Detalles Bibliográficos
Autores principales:	Malik, G. A., Robertson, N. P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2017
Materias:	Journal Club
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5306064/ https://www.ncbi.nlm.nih.gov/pubmed/28120041 http://dx.doi.org/10.1007/s00415-017-8395-1

Ejemplares similares

New treatments in Alzheimer’s disease
por: Pickrell, William O., et al.
Publicado: (2018)

Seizures in Alzheimer’s disease: is there more beneath the surface?
por: Edwards, Marc, et al.
Publicado: (2017)

Cerebral amyloid angiopathy: subtypes, treatment and role in cognitive impairment
por: McLauchlan, D., et al.
Publicado: (2017)

Disease-modifying treatments in Alzheimer’s disease
por: Edwards, Marc, et al.
Publicado: (2023)

Genetics of disease severity in multiple sclerosis, Alzheimer’s disease, and Huntington’s disease: rejuvenating genome-wide association studies
por: Hrastelj, James, et al.
Publicado: (2017)

Path from discovery to recovery: therapeutic and diagnostic advances in Alzheimer's dementia
por: Saw, Aung M., et al.
Publicado: (2023)

Stem cells in the treatment of central nervous system disease
por: McLauchlan, Duncan, et al.
Publicado: (2018)

Cluster headache: an overview of established and emerging treatments
por: Al-Ansari, A., et al.
Publicado: (2019)

Autoimmune encephalitis: clinical presentation, investigation and treatment
por: Al-Ansari, A., et al.
Publicado: (2021)

Cerebral venous thrombosis: clinical predictors and emerging treatments
por: Al-Ansari, A., et al.
Publicado: (2020)

Postural orthostatic tachycardia syndrome: insights into pathogenesis and treatment
por: Al-Ansari, A., et al.
Publicado: (2021)

B cell treatments for multiple sclerosis
por: McLauchlan, D., et al.
Publicado: (2017)

Vaccine-induced immune thrombosis and thrombocytopaenia: incidence, mechanism and treatment
por: Hrastelj, J., et al.
Publicado: (2021)

Myelin oligodendrocyte glycoprotein antibody-associated disease: characterising clinical disease
por: Willis, M. D., et al.
Publicado: (2018)

Repurposing drugs to treat neurological diseases
por: Massey, T. H., et al.
Publicado: (2018)

Idiopathic rapid eye movement sleep behaviour disorder: a potential gateway to the development of disease-modifying treatments in neurodegenerative disorders
por: Peall, K. J., et al.
Publicado: (2016)

The economic burden of chronic neurological disease
por: Wynford-Thomas, R., et al.
Publicado: (2017)

An update on treatments in myasthenia gravis
por: Jones, Lliwen A., et al.
Publicado: (2016)

Creutzfeldt–Jacob disease: new directions in diagnosis and therapeutics
por: Al-Ansari, Aseel, et al.
Publicado: (2017)

Multiple sclerosis: early indicators of disease and assessing future risk
por: Willis, M. D., et al.
Publicado: (2020)

Treatment of progressive multifocal leukoencephalopathy
por: Castle, Daniel, et al.
Publicado: (2019)

Cannabidiol as a treatment for epilepsy
por: Pickrell, William O., et al.
Publicado: (2017)

Stem cell treatment for multiple sclerosis
por: Owen Pickrell, W., et al.
Publicado: (2016)

Response to SARS-CoV-2 vaccination in multiple sclerosis patients on disease modifying therapies
por: Allman, M., et al.
Publicado: (2022)

Emerging treatments for neuromyelitis optica spectrum disorder
por: Wynford-Thomas, Ray, et al.
Publicado: (2020)

Alternatives to intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyradiculoneuropathy
por: Castle, Dan, et al.
Publicado: (2019)

Amyotrophic lateral sclerosis: an update on treatments from clinical trials
por: Wynford-Thomas, Ray, et al.
Publicado: (2023)

Clinical patterns in CADASIL
por: Gailani, G., et al.
Publicado: (2022)

Innovative biomarkers to predict unfavourable outcomes after initiating multiple sclerosis treatment
por: Kreft, Karim L., et al.
Publicado: (2022)

New ways of looking at an old disease: the reimagination of epilepsy
por: Mitchell, Clinton J., et al.
Publicado: (2016)

Advances in the use of stem cell transplants in the treatment of multiple sclerosis
por: Thomas, Rachel, et al.
Publicado: (2022)

Sleep disorders in Parkinson’s disease
por: Hawken, Jonathan, et al.
Publicado: (2022)

The role of skin biopsy in differentiating idiopathic Parkinson’s disease from other types of parkinsonism
por: Wynford-Thomas, Ray, et al.
Publicado: (2015)

The gut microbiome: neurological development and disease
por: Miah, Latif, et al.
Publicado: (2022)

Anti-epileptics and pregnancy: an update
por: Al-Ansari, A., et al.
Publicado: (2018)

Autoimmune encephalitis: frequency and prognosis
por: Al-Ansari, A., et al.
Publicado: (2019)

Parkinson, Alzheimer und MS in Coronazeiten
por: Wietelmann, Detlef
Publicado: (2021)

MRI-guided focused ultrasound: new hope for drug-resistant neurological conditions
por: Bari, S., et al.
Publicado: (2023)

Clinical trials in myasthenia gravis
por: Mahmood, A., et al.
Publicado: (2023)

Why antisense could make sense for neurodegeneration
por: Massey, T. H., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_rlkvbb9gspvricuse8e0io4avi